0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Radioisotope Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-14H14175
Home | Market Reports | Health| Health Conditions| Cancer
Global Radioisotope Therapy Market Research Report 2023
BUY CHAPTERS

Radioisotope Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-14H14175
Report
October 2024
Pages:115
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Radioisotope Therapy - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Radioisotope Therapy - Market

Radioisotope Therapy - Market

Radioisotope Therapy uses a radioactive drug that seeks out and destroys cancer cells while minimizing damage to neighboring healthy cells.
The global market for Radioisotope Therapy was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Radioisotope Therapy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Radioisotope Therapy by region & country, by Type, and by Application.
The Radioisotope Therapy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radioisotope Therapy.
Market Segmentation

Scope of Radioisotope Therapy - Market Report

Report Metric Details
Report Name Radioisotope Therapy - Market
CAGR 5%
Segment by Type:
  • External Beam
  • Internal Beam
Segment by Application
  • Thyroid Cancer
  • Bile Duct Cancer
  • Liver Cancer
  • Bone Metastases
  • Neuroblastoma
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Siemens Healthineers, GE Healthcare, Philips Healthcare, Varian Medical Systems, Elekta, Hitachi Medical Corporation, IBA Worldwide, Accuray Incorporated, Advanced Accelerator Applications, Nordion Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Radioisotope Therapy manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Radioisotope Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Radioisotope Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Radioisotope Therapy - Market report?

Ans: The main players in the Radioisotope Therapy - Market are Siemens Healthineers, GE Healthcare, Philips Healthcare, Varian Medical Systems, Elekta, Hitachi Medical Corporation, IBA Worldwide, Accuray Incorporated, Advanced Accelerator Applications, Nordion Inc.

What are the Application segmentation covered in the Radioisotope Therapy - Market report?

Ans: The Applications covered in the Radioisotope Therapy - Market report are Thyroid Cancer, Bile Duct Cancer, Liver Cancer, Bone Metastases, Neuroblastoma, Others

What are the Type segmentation covered in the Radioisotope Therapy - Market report?

Ans: The Types covered in the Radioisotope Therapy - Market report are External Beam, Internal Beam

1 Market Overview
1.1 Radioisotope Therapy Product Introduction
1.2 Global Radioisotope Therapy Market Size Forecast
1.3 Radioisotope Therapy Market Trends & Drivers
1.3.1 Radioisotope Therapy Industry Trends
1.3.2 Radioisotope Therapy Market Drivers & Opportunity
1.3.3 Radioisotope Therapy Market Challenges
1.3.4 Radioisotope Therapy Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Radioisotope Therapy Players Revenue Ranking (2023)
2.2 Global Radioisotope Therapy Revenue by Company (2019-2024)
2.3 Key Companies Radioisotope Therapy Manufacturing Base Distribution and Headquarters
2.4 Key Companies Radioisotope Therapy Product Offered
2.5 Key Companies Time to Begin Mass Production of Radioisotope Therapy
2.6 Radioisotope Therapy Market Competitive Analysis
2.6.1 Radioisotope Therapy Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Radioisotope Therapy Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioisotope Therapy as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 External Beam
3.1.2 Internal Beam
3.2 Global Radioisotope Therapy Sales Value by Type
3.2.1 Global Radioisotope Therapy Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Radioisotope Therapy Sales Value, by Type (2019-2030)
3.2.3 Global Radioisotope Therapy Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Thyroid Cancer
4.1.2 Bile Duct Cancer
4.1.3 Liver Cancer
4.1.4 Bone Metastases
4.1.5 Neuroblastoma
4.1.6 Others
4.2 Global Radioisotope Therapy Sales Value by Application
4.2.1 Global Radioisotope Therapy Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Radioisotope Therapy Sales Value, by Application (2019-2030)
4.2.3 Global Radioisotope Therapy Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Radioisotope Therapy Sales Value by Region
5.1.1 Global Radioisotope Therapy Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Radioisotope Therapy Sales Value by Region (2019-2024)
5.1.3 Global Radioisotope Therapy Sales Value by Region (2025-2030)
5.1.4 Global Radioisotope Therapy Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Radioisotope Therapy Sales Value, 2019-2030
5.2.2 North America Radioisotope Therapy Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Radioisotope Therapy Sales Value, 2019-2030
5.3.2 Europe Radioisotope Therapy Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Radioisotope Therapy Sales Value, 2019-2030
5.4.2 Asia Pacific Radioisotope Therapy Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Radioisotope Therapy Sales Value, 2019-2030
5.5.2 South America Radioisotope Therapy Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Radioisotope Therapy Sales Value, 2019-2030
5.6.2 Middle East & Africa Radioisotope Therapy Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Radioisotope Therapy Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Radioisotope Therapy Sales Value
6.3 United States
6.3.1 United States Radioisotope Therapy Sales Value, 2019-2030
6.3.2 United States Radioisotope Therapy Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Radioisotope Therapy Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Radioisotope Therapy Sales Value, 2019-2030
6.4.2 Europe Radioisotope Therapy Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Radioisotope Therapy Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Radioisotope Therapy Sales Value, 2019-2030
6.5.2 China Radioisotope Therapy Sales Value by Type (%), 2023 VS 2030
6.5.3 China Radioisotope Therapy Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Radioisotope Therapy Sales Value, 2019-2030
6.6.2 Japan Radioisotope Therapy Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Radioisotope Therapy Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Radioisotope Therapy Sales Value, 2019-2030
6.7.2 South Korea Radioisotope Therapy Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Radioisotope Therapy Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Radioisotope Therapy Sales Value, 2019-2030
6.8.2 Southeast Asia Radioisotope Therapy Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Radioisotope Therapy Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Radioisotope Therapy Sales Value, 2019-2030
6.9.2 India Radioisotope Therapy Sales Value by Type (%), 2023 VS 2030
6.9.3 India Radioisotope Therapy Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Siemens Healthineers
7.1.1 Siemens Healthineers Profile
7.1.2 Siemens Healthineers Main Business
7.1.3 Siemens Healthineers Radioisotope Therapy Products, Services and Solutions
7.1.4 Siemens Healthineers Radioisotope Therapy Revenue (US$ Million) & (2019-2024)
7.1.5 Siemens Healthineers Recent Developments
7.2 GE Healthcare
7.2.1 GE Healthcare Profile
7.2.2 GE Healthcare Main Business
7.2.3 GE Healthcare Radioisotope Therapy Products, Services and Solutions
7.2.4 GE Healthcare Radioisotope Therapy Revenue (US$ Million) & (2019-2024)
7.2.5 GE Healthcare Recent Developments
7.3 Philips Healthcare
7.3.1 Philips Healthcare Profile
7.3.2 Philips Healthcare Main Business
7.3.3 Philips Healthcare Radioisotope Therapy Products, Services and Solutions
7.3.4 Philips Healthcare Radioisotope Therapy Revenue (US$ Million) & (2019-2024)
7.3.5 Varian Medical Systems Recent Developments
7.4 Varian Medical Systems
7.4.1 Varian Medical Systems Profile
7.4.2 Varian Medical Systems Main Business
7.4.3 Varian Medical Systems Radioisotope Therapy Products, Services and Solutions
7.4.4 Varian Medical Systems Radioisotope Therapy Revenue (US$ Million) & (2019-2024)
7.4.5 Varian Medical Systems Recent Developments
7.5 Elekta
7.5.1 Elekta Profile
7.5.2 Elekta Main Business
7.5.3 Elekta Radioisotope Therapy Products, Services and Solutions
7.5.4 Elekta Radioisotope Therapy Revenue (US$ Million) & (2019-2024)
7.5.5 Elekta Recent Developments
7.6 Hitachi Medical Corporation
7.6.1 Hitachi Medical Corporation Profile
7.6.2 Hitachi Medical Corporation Main Business
7.6.3 Hitachi Medical Corporation Radioisotope Therapy Products, Services and Solutions
7.6.4 Hitachi Medical Corporation Radioisotope Therapy Revenue (US$ Million) & (2019-2024)
7.6.5 Hitachi Medical Corporation Recent Developments
7.7 IBA Worldwide
7.7.1 IBA Worldwide Profile
7.7.2 IBA Worldwide Main Business
7.7.3 IBA Worldwide Radioisotope Therapy Products, Services and Solutions
7.7.4 IBA Worldwide Radioisotope Therapy Revenue (US$ Million) & (2019-2024)
7.7.5 IBA Worldwide Recent Developments
7.8 Accuray Incorporated
7.8.1 Accuray Incorporated Profile
7.8.2 Accuray Incorporated Main Business
7.8.3 Accuray Incorporated Radioisotope Therapy Products, Services and Solutions
7.8.4 Accuray Incorporated Radioisotope Therapy Revenue (US$ Million) & (2019-2024)
7.8.5 Accuray Incorporated Recent Developments
7.9 Advanced Accelerator Applications
7.9.1 Advanced Accelerator Applications Profile
7.9.2 Advanced Accelerator Applications Main Business
7.9.3 Advanced Accelerator Applications Radioisotope Therapy Products, Services and Solutions
7.9.4 Advanced Accelerator Applications Radioisotope Therapy Revenue (US$ Million) & (2019-2024)
7.9.5 Advanced Accelerator Applications Recent Developments
7.10 Nordion Inc.
7.10.1 Nordion Inc. Profile
7.10.2 Nordion Inc. Main Business
7.10.3 Nordion Inc. Radioisotope Therapy Products, Services and Solutions
7.10.4 Nordion Inc. Radioisotope Therapy Revenue (US$ Million) & (2019-2024)
7.10.5 Nordion Inc. Recent Developments
8 Industry Chain Analysis
8.1 Radioisotope Therapy Industrial Chain
8.2 Radioisotope Therapy Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Radioisotope Therapy Sales Model
8.5.2 Sales Channel
8.5.3 Radioisotope Therapy Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Radioisotope Therapy Market Trends
    Table 2. Radioisotope Therapy Market Drivers & Opportunity
    Table 3. Radioisotope Therapy Market Challenges
    Table 4. Radioisotope Therapy Market Restraints
    Table 5. Global Radioisotope Therapy Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Radioisotope Therapy Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Radioisotope Therapy Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Radioisotope Therapy Product Type
    Table 9. Key Companies Time to Begin Mass Production of Radioisotope Therapy
    Table 10. Global Radioisotope Therapy Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioisotope Therapy as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Radioisotope Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Radioisotope Therapy Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Radioisotope Therapy Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Radioisotope Therapy Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Radioisotope Therapy Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Radioisotope Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Radioisotope Therapy Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Radioisotope Therapy Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Radioisotope Therapy Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Radioisotope Therapy Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Radioisotope Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Radioisotope Therapy Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Radioisotope Therapy Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Radioisotope Therapy Sales Value by Region (2019-2024) & (%)
    Table 27. Global Radioisotope Therapy Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Radioisotope Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Radioisotope Therapy Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Radioisotope Therapy Sales Value, (2025-2030) & (US$ Million)
    Table 31. Siemens Healthineers Basic Information List
    Table 32. Siemens Healthineers Description and Business Overview
    Table 33. Siemens Healthineers Radioisotope Therapy Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Radioisotope Therapy Business of Siemens Healthineers (2019-2024)
    Table 35. Siemens Healthineers Recent Developments
    Table 36. GE Healthcare Basic Information List
    Table 37. GE Healthcare Description and Business Overview
    Table 38. GE Healthcare Radioisotope Therapy Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Radioisotope Therapy Business of GE Healthcare (2019-2024)
    Table 40. GE Healthcare Recent Developments
    Table 41. Philips Healthcare Basic Information List
    Table 42. Philips Healthcare Description and Business Overview
    Table 43. Philips Healthcare Radioisotope Therapy Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Radioisotope Therapy Business of Philips Healthcare (2019-2024)
    Table 45. Philips Healthcare Recent Developments
    Table 46. Varian Medical Systems Basic Information List
    Table 47. Varian Medical Systems Description and Business Overview
    Table 48. Varian Medical Systems Radioisotope Therapy Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Radioisotope Therapy Business of Varian Medical Systems (2019-2024)
    Table 50. Varian Medical Systems Recent Developments
    Table 51. Elekta Basic Information List
    Table 52. Elekta Description and Business Overview
    Table 53. Elekta Radioisotope Therapy Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Radioisotope Therapy Business of Elekta (2019-2024)
    Table 55. Elekta Recent Developments
    Table 56. Hitachi Medical Corporation Basic Information List
    Table 57. Hitachi Medical Corporation Description and Business Overview
    Table 58. Hitachi Medical Corporation Radioisotope Therapy Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Radioisotope Therapy Business of Hitachi Medical Corporation (2019-2024)
    Table 60. Hitachi Medical Corporation Recent Developments
    Table 61. IBA Worldwide Basic Information List
    Table 62. IBA Worldwide Description and Business Overview
    Table 63. IBA Worldwide Radioisotope Therapy Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Radioisotope Therapy Business of IBA Worldwide (2019-2024)
    Table 65. IBA Worldwide Recent Developments
    Table 66. Accuray Incorporated Basic Information List
    Table 67. Accuray Incorporated Description and Business Overview
    Table 68. Accuray Incorporated Radioisotope Therapy Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Radioisotope Therapy Business of Accuray Incorporated (2019-2024)
    Table 70. Accuray Incorporated Recent Developments
    Table 71. Advanced Accelerator Applications Basic Information List
    Table 72. Advanced Accelerator Applications Description and Business Overview
    Table 73. Advanced Accelerator Applications Radioisotope Therapy Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Radioisotope Therapy Business of Advanced Accelerator Applications (2019-2024)
    Table 75. Advanced Accelerator Applications Recent Developments
    Table 76. Nordion Inc. Basic Information List
    Table 77. Nordion Inc. Description and Business Overview
    Table 78. Nordion Inc. Radioisotope Therapy Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Radioisotope Therapy Business of Nordion Inc. (2019-2024)
    Table 80. Nordion Inc. Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Radioisotope Therapy Downstream Customers
    Table 84. Radioisotope Therapy Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Radioisotope Therapy Product Picture
    Figure 2. Global Radioisotope Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Radioisotope Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 4. Radioisotope Therapy Report Years Considered
    Figure 5. Global Radioisotope Therapy Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Radioisotope Therapy Revenue in 2023
    Figure 7. Radioisotope Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. External Beam Picture
    Figure 9. Internal Beam Picture
    Figure 10. Global Radioisotope Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Radioisotope Therapy Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Thyroid Cancer
    Figure 13. Product Picture of Bile Duct Cancer
    Figure 14. Product Picture of Liver Cancer
    Figure 15. Product Picture of Bone Metastases
    Figure 16. Product Picture of Neuroblastoma
    Figure 17. Product Picture of Others
    Figure 18. Global Radioisotope Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Radioisotope Therapy Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America Radioisotope Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America Radioisotope Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe Radioisotope Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe Radioisotope Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific Radioisotope Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific Radioisotope Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America Radioisotope Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America Radioisotope Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa Radioisotope Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa Radioisotope Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions Radioisotope Therapy Sales Value (%), (2019-2030)
    Figure 31. United States Radioisotope Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States Radioisotope Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States Radioisotope Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe Radioisotope Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe Radioisotope Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe Radioisotope Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 37. China Radioisotope Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China Radioisotope Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 39. China Radioisotope Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan Radioisotope Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan Radioisotope Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan Radioisotope Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea Radioisotope Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea Radioisotope Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea Radioisotope Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia Radioisotope Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Radioisotope Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia Radioisotope Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 49. India Radioisotope Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India Radioisotope Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 51. India Radioisotope Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 52. Radioisotope Therapy Industrial Chain
    Figure 53. Radioisotope Therapy Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Hematologic Malignancies Detection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-20M14708
Fri Nov 22 00:00:00 UTC 2024

Add to Cart

Stereotactic Radiosurgery (SRS) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-14C14333
Fri Nov 08 00:00:00 UTC 2024

Add to Cart

Cancer Diagnostic Test Kits - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-28P13808
Fri Nov 08 00:00:00 UTC 2024

Add to Cart

Gamma Knife Radiosurgery (GKRS) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-29R14086
Fri Nov 08 00:00:00 UTC 2024

Add to Cart